$10 is a stretch, that would imply money coming in from several drugs. At best in a few years we will have the first drug pulling $1B US pa. If we have no further dilution and a corresponding PE of 20 that would see the mcap at $20B ish and a SP some 100 x . So $6. But dilution and delays could see this at $4 and a year later.
I think it is less fanciful to think we might get a rerate based on efficacy of PYC001 late into next year taking us back over 20c again.
Hopefully earlier than that, but that would take some sort of deal I think.
Ann: New Drug For Major Kidney Disease Effective In Human Models, page-36
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.010(7.69%) |
Mkt cap ! $653.2M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.0¢ | $1.446M | 10.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 252759 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 113762 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |